BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 6, 2004
View Archived Issues
Vernalis highlights interim pipeline progress
Read More
Pain Therapeutics reports 2003 progress
Read More
Millennium highlights year-end and Q4 2003 progress
Read More
Connetics makes substantial progress during Q4 2003
Read More
Biological effects and safety of MDX-H210 plus filgrastim in advanced breast cancer
Read More
Three series of hypolipidemic agents presented by Aventis Pharma
Read More
New liver-selective GR antagonists prepared and tested at Abbott
Read More
Akzo Nobel describes new CB1 agonists with analgesic activity
Read More
Novel histamine H3 antagonists in early development at Schering-Plough
Read More
Novel cathepsin inhibitors described by AxyS researchers
Read More
Acadia claims novel 5-HT2A inhibitors with potential as antipsychotics
Read More
Novel muscarinic M3 antagonists identified at Almirall Prodesfarma
Read More
Biovitrum claims 5-HT6 modulators for obesity and other disorders
Read More
IP3R3 involved in peritoneal metastasis of gastric cancers
Read More
JNJ-5207787, a novel neuropeptide Y Y2 receptor antagonist, may be a potent pharmacological tool
Read More
Novel selective and orally active oxytocin receptor antagonist for the prevention of preterm labor
Read More
Vertex and Novartis amend protein kinase collaboration agreement
Read More
NeuroSearch plans two phase II studies of NS-1209
Read More
Sanofi-Synthelabo acquires Taisho's stake in Japanese joint venture
Read More
Phase I ThermoDox protocol amendments allowed
Read More
Orphan drug status sought for Myodur
Read More
ABX-PTH enters phase I trial in patients with secondary hyperparathyroidism
Read More
Cytos to supply Alzheimer's Immunodrug to Novartis
Read More
Phase II trials of extended-release Sonata cleared to commence
Read More
IND filing to study Antegren for rheumatoid arthritis
Read More
New Imitrex available for rapid disintegration in stomach
Read More
Homspera shows potential utility for Hong Kong virus in mouse study
Read More
Gilead reports long-term effects of Viread in naive HIV-infected patients
Read More
Anti-GPIIb/IIIa therapy enhances the effects of intraarterial TNK-tPA in stroke
Read More